J. Pépin

Infectious Diseases · Canadian Medical Association Journal · 2004–2014

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

• Infectious Diseases — 16 citations into it; #259 of 589 by trust here, #129 by citations

Whom J. Pépin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Louis Valiquette
2. H. Goossens

Who trusts J. Pépin overall

1. J. Bartlett
2. Louis Valiquette
3. E. Dubberke
4. J. Siegel
5. Benoît Cossette
6. M. Bauer
7. E. Kuijper
8. J. H. Morse
9. E. Rhinehart
10. L. Mcfarland

Papers from J. Pépin's perspective

Ordered by how strongly the researchers J. Pépin trusts endorse each paper. Same corpus, a different order for every researcher.

1. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. (New England Journal of Medicine)
2. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity (Canadian Medical Association Journal)
3. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. (The Lancet)
4. Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications (Annals of Surgery)
5. Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults (Clinical Infectious Diseases)
6. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. (Clinical Infectious Diseases)
7. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies (Canadian Medical Association Journal)
8. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. (The Lancet)
9. A Large Outbreak of Clostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use (Infection Control & Hospital Epidemiology)
10. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. (Clinical Infectious Diseases)

Their papers

• Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. (2005) — 1,475 citations
• The early spread and epidemic ignition of HIV-1 in human populations (2014) — 700 citations
• Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. (2005) — 1,041 citations
• Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. (2005) — 608 citations
• Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec (2005) — 668 citations
• Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity (2004) — 1,172 citations